Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12623001309673Phase 4Recruiting
Phase 4, randomised, double-blind trial of ropivacaine and morphine in postoperative pain (2 arms), sponsored by Tim Cheok. Primary endpoint: Dynamic pain score. Started Feb 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12623001309673.